1. An evaluation of a national oral rehydration solution and zinc scale-up program in Kenya between 2011 and 2016
- Author
-
Felix Lam, Betty Wariari, Rosemary Kihoto, Zachary Mwangi, Santau Migiro, Peter Cherutich, Samuel Ogolla, Kate Schroder, McDonald Obudho, Collins Cheruiyot, Khadija Abdala, Michael Musyoka, Leslie Wentworth, and Audrey Battu
- Subjects
Diarrhea ,Male ,030231 tropical medicine ,Population ,chemistry.chemical_element ,Zinc ,03 medical and health sciences ,Household survey ,0302 clinical medicine ,Environmental health ,Humans ,Medicine ,030212 general & internal medicine ,education ,Cause of death ,education.field_of_study ,Under-five ,business.industry ,Health Policy ,Infant, Newborn ,Public Health, Environmental and Occupational Health ,Infant ,Coverage data ,Research Theme 1: Clinton Health Access Initiative ,Kenya ,Confidence interval ,Government Programs ,Treatment Outcome ,chemistry ,Child, Preschool ,Health Care Surveys ,Rehydration Solutions ,Fluid Therapy ,Female ,medicine.symptom ,business ,Program Evaluation - Abstract
Background In Kenya, diarrheal disease is the second leading cause of death among children under five. The Government of Kenya launched a national plan to increase coverage of oral rehydration solution (ORS) and zinc by addressing demand and supply-side barriers. This study evaluates progress of ORS and zinc uptake in Kenya according to the national plan from 2011 to 2016. Methods In 2016, we conducted a nationally representative population-based household survey to estimate coverage of ORS and zinc for treatment of diarrhea cases among children under five. We also used ORS and zinc coverage data from the two most recent Kenya Demographic and Health Surveys in 2008/09 and 2014 to estimate annual changes in coverage rates during the program period. Based on these inputs, we used the Lives Saved Tool to estimate the number of diarrhea deaths averted between 2011 and 2016 due to increased use of ORS and zinc. Results The 2016 survey results showed that ORS coverage was 42% (95% confidence interval (CI) = 38%, 47%) and zinc coverage was 18% (95% CI = 15%, 23%). The estimated coverage for the combined use of ORS and zinc was 15% in 2016 (95% CI = 12%, 19%). Compared to 2011, an additional 3340 (sensitivity bounds = 2 670, 3 920) diarrhea deaths among children under five were averted due to increases in ORS and zinc coverage. Conclusions Kenya was successful in catalyzing uptake of combined treatment with ORS and zinc, which rose from 0.8% in 2011 to 15% in 2016. Ongoing efforts are necessary to further build on these gains.
- Published
- 2019
- Full Text
- View/download PDF